Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths

Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders

Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression

Findings show noninferior outcomes at three months versus cognitive behavioral therapy

However, survivors had more problems with mobility, pain or discomfort, anxiety or depression at one year than controls

Adults with disabilities more often report that the pandemic makes it harder for them to access care, medication

Benefits include cognitive and functional outcomes even for severely affected patients

While nearly one in three will experience points of remission of ADHD symptoms, most experience recurrence over time and few outgrow it

Higher scores on Lifestyle for Brain Health index linked to higher volumes of white matter hyperintensities, lower scores for cognitive function

Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms